{"id":"https://openalex.org/W2998712907","doi":null,"title":"A combination of the PI3K pathway inhibitor plus cell cycle pathway inhibitor to combat endocrine resistance in hormone receptor-positive breast cancer: a genomic algorithm-based treatment approach.","display_name":"A combination of the PI3K pathway inhibitor plus cell cycle pathway inhibitor to combat endocrine resistance in hormone receptor-positive breast cancer: a genomic algorithm-based treatment approach.","publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W2998712907","mag":"2998712907","pmid":"https://pubmed.ncbi.nlm.nih.gov/30662797","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6325472"},"language":"en","primary_location":{"id":"pmh:oai:europepmc.org:5311011","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6325472","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC6325472","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061604198","display_name":"Anita Gul","orcid":"https://orcid.org/0000-0003-0785-5100","observed_orcids":["https://orcid.org/0000-0003-0785-5100"]},"institutions":[{"id":"https://openalex.org/I1322918889","display_name":"United States Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889"]},{"id":"https://openalex.org/I189957204","display_name":"University of South Dakota","ror":"https://ror.org/0043h8f16","country_code":"US","type":"education","lineage":["https://openalex.org/I189957204"]},{"id":"https://openalex.org/I4210124429","display_name":"Sioux Falls VA Health Care System","ror":"https://ror.org/02vjn2106","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210117924","https://openalex.org/I4210124429"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anita Gul","raw_affiliation_strings":["VA Medical Center Sioux Falls, SD, USA","Department of Internal Medicine, SSOM, University of South Dakota SD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VA Medical Center Sioux Falls, SD, USA","institution_ids":["https://openalex.org/I1322918889","https://openalex.org/I4210124429"]},{"raw_affiliation_string":"Department of Internal Medicine, SSOM, University of South Dakota SD, USA","institution_ids":["https://openalex.org/I189957204"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066451553","display_name":"Brain Leyland-Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799572201","display_name":"Avera Health","ror":"https://ror.org/05nter171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799572201"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brain Leyland-Jones","raw_affiliation_strings":["Department of Molecular and Experimental Medicine, Avera Cancer Institute Sioux Falls, SD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Experimental Medicine, Avera Cancer Institute Sioux Falls, SD, USA","institution_ids":["https://openalex.org/I2799572201"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012509754","display_name":"Nandini Dey","orcid":"https://orcid.org/0000-0002-5533-8784","observed_orcids":["https://orcid.org/0000-0002-5533-8784"]},"institutions":[{"id":"https://openalex.org/I189957204","display_name":"University of South Dakota","ror":"https://ror.org/0043h8f16","country_code":"US","type":"education","lineage":["https://openalex.org/I189957204"]},{"id":"https://openalex.org/I2799572201","display_name":"Avera Health","ror":"https://ror.org/05nter171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799572201"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nandini Dey","raw_affiliation_strings":["Department of Molecular and Experimental Medicine, Avera Cancer Institute Sioux Falls, SD, USA","Department of Internal Medicine, SSOM, University of South Dakota SD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Experimental Medicine, Avera Cancer Institute Sioux Falls, SD, USA","institution_ids":["https://openalex.org/I2799572201"]},{"raw_affiliation_string":"Department of Internal Medicine, SSOM, University of South Dakota SD, USA","institution_ids":["https://openalex.org/I189957204"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112103541","display_name":"Pradip K. De","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189957204","display_name":"University of South Dakota","ror":"https://ror.org/0043h8f16","country_code":"US","type":"education","lineage":["https://openalex.org/I189957204"]},{"id":"https://openalex.org/I2799572201","display_name":"Avera Health","ror":"https://ror.org/05nter171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799572201"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pradip De","raw_affiliation_strings":["Department of Molecular and Experimental Medicine, Avera Cancer Institute Sioux Falls, SD, USA","Department of Internal Medicine, SSOM, University of South Dakota SD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Experimental Medicine, Avera Cancer Institute Sioux Falls, SD, USA","institution_ids":["https://openalex.org/I2799572201"]},{"raw_affiliation_string":"Department of Internal Medicine, SSOM, University of South Dakota SD, USA","institution_ids":["https://openalex.org/I189957204"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.9225,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.94094291,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"8","issue":"12","first_page":"2359","last_page":"2376"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.7120000123977661},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.8650000095367432},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.9290000200271606},{"id":"https://openalex.org/keywords/cell-cycle-pathway","display_name":"cell cycle pathway","score":0.7689999938011169},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7950000166893005},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5929999947547913},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.4950000047683716},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.40299999713897705}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.8282400369644165},{"id":"https://openalex.org/C199649820","wikidata":"https://www.wikidata.org/wiki/Q14911762","display_name":"Cyclin-dependent kinase 6","level":5,"score":0.7159271836280823},{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.6881664395332336},{"id":"https://openalex.org/C2780265364","wikidata":"https://www.wikidata.org/wiki/Q5009957","display_name":"CDKN2A","level":3,"score":0.6778210401535034},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6507943868637085},{"id":"https://openalex.org/C51853150","wikidata":"https://www.wikidata.org/wiki/Q14911754","display_name":"Cyclin-dependent kinase 4","level":5,"score":0.6231233477592468},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5001232624053955},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.48729026317596436},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.47509801387786865},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.469624787569046},{"id":"https://openalex.org/C199835354","wikidata":"https://www.wikidata.org/wiki/Q15311861","display_name":"Cyclin D1","level":4,"score":0.4678203761577606},{"id":"https://openalex.org/C2778298596","wikidata":"https://www.wikidata.org/wiki/Q17143494","display_name":"CDK inhibitor","level":5,"score":0.465457022190094},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.4472200572490692},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4032083749771118},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36002880334854126},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3376960754394531},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3367684483528137},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.304837167263031},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.1334228217601776},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.12512695789337158},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.06974935531616211}],"mesh":[],"locations_count":4,"locations":[{"id":"pmh:oai:europepmc.org:5311011","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6325472","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:30662797","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30662797","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6325472","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6325472/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Am J Cancer Res","raw_type":"Text"},{"id":"mag:2998712907","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30662797","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:europepmc.org:5311011","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6325472","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":87,"referenced_works":["https://openalex.org/W83682826","https://openalex.org/W1453600927","https://openalex.org/W1464936406","https://openalex.org/W1523693806","https://openalex.org/W1829077072","https://openalex.org/W1861759122","https://openalex.org/W1932574503","https://openalex.org/W1946355969","https://openalex.org/W1961026612","https://openalex.org/W1966623655","https://openalex.org/W1969255091","https://openalex.org/W1975402264","https://openalex.org/W1975570973","https://openalex.org/W1991054314","https://openalex.org/W1995916005","https://openalex.org/W2002004879","https://openalex.org/W2006216237","https://openalex.org/W2009886463","https://openalex.org/W2012877952","https://openalex.org/W2013956549","https://openalex.org/W2016450639","https://openalex.org/W2019420548","https://openalex.org/W2020330574","https://openalex.org/W2021145743","https://openalex.org/W2025215722","https://openalex.org/W2026842712","https://openalex.org/W2031131661","https://openalex.org/W2032144589","https://openalex.org/W2033672070","https://openalex.org/W2044702943","https://openalex.org/W2046410395","https://openalex.org/W2062542032","https://openalex.org/W2076941162","https://openalex.org/W2089655089","https://openalex.org/W2089738145","https://openalex.org/W2102004296","https://openalex.org/W2105084636","https://openalex.org/W2111324624","https://openalex.org/W2112780046","https://openalex.org/W2115826043","https://openalex.org/W2117357260","https://openalex.org/W2125785648","https://openalex.org/W2127306096","https://openalex.org/W2132052921","https://openalex.org/W2132846837","https://openalex.org/W2137035181","https://openalex.org/W2137620209","https://openalex.org/W2144790402","https://openalex.org/W2147114673","https://openalex.org/W2148345265","https://openalex.org/W2153607816","https://openalex.org/W2154472114","https://openalex.org/W2155609574","https://openalex.org/W2161977537","https://openalex.org/W2162003888","https://openalex.org/W2166631738","https://openalex.org/W2167188058","https://openalex.org/W2167264978","https://openalex.org/W2169106672","https://openalex.org/W2216094174","https://openalex.org/W2219817965","https://openalex.org/W2260659963","https://openalex.org/W2290950904","https://openalex.org/W2309969893","https://openalex.org/W2343358448","https://openalex.org/W2415372857","https://openalex.org/W2470394874","https://openalex.org/W2516966009","https://openalex.org/W2528767298","https://openalex.org/W2537675006","https://openalex.org/W2558360748","https://openalex.org/W2560367415","https://openalex.org/W2589036504","https://openalex.org/W2617303101","https://openalex.org/W2619858681","https://openalex.org/W2750328162","https://openalex.org/W2759118902","https://openalex.org/W2763875663","https://openalex.org/W2771397989","https://openalex.org/W2790152406","https://openalex.org/W2791176983","https://openalex.org/W2794154000","https://openalex.org/W2797268891","https://openalex.org/W2802776309","https://openalex.org/W4300639531","https://openalex.org/W4301159569","https://openalex.org/W7097910419"],"related_works":["https://openalex.org/W3088405851","https://openalex.org/W3049108467","https://openalex.org/W2969690362","https://openalex.org/W2036061214","https://openalex.org/W3016495342","https://openalex.org/W4417439418","https://openalex.org/W3095588873","https://openalex.org/W2956135912","https://openalex.org/W3083198770","https://openalex.org/W2946577169"],"abstract_inverted_index":{"loss":[0],"have":[1,59],"not":[2],"sorted":[3],"out":[4],"biomarkers":[5],"useful":[6],"for":[7],"the":[8,12,39,44,64,72,78,88,104,109],"purpose.":[9],"One":[10],"of":[11,90,106,111],"most":[13],"important":[14],"clinical":[15,99],"questions":[16],"is":[17],"how":[18,84],"to":[19,37,61],"use":[20,36],"a":[21,31],"CDK4/6":[22,40],"inhibitor":[23],"with":[24,43],"other":[25],"targeted":[26],"therapies.":[27],"Here":[28],"we":[29,58],"provide":[30],"rationale":[32],"that":[33],"oncologists":[34],"can":[35],"sequence":[38],"inhibitors":[41,114],"along":[42],"PI3K-AKT-mTOR":[45],"pathway-specific":[46],"inhibitor(s);":[47],"future":[48],"data":[49],"will":[50],"better":[51],"guide":[52],"this":[53,56],"approach.":[54],"In":[55],"review":[57],"tried":[60],"(a)":[62],"describe":[63],"specific":[65],"cellular":[66],"signals":[67],"initiated":[68],"following":[69],"alterations":[70],"in":[71,97,117],"cell":[73,93,112],"cycle":[74,94,113],"pathway":[75,80],"genes":[76],"and":[77,92,101],"PI3K":[79,91],"genes,":[81],"(b)":[82],"interrogate":[83],"these":[85],"alterations/co-alterations":[86],"influence":[87],"action":[89],"pathway-targeted":[95],"drugs":[96],"different":[98],"trials":[100],"(c)":[102],"understand":[103],"role":[105],"co-alterations":[107],"towards":[108],"development":[110],"induced":[115],"drug-resistance":[116],"ER+":[118],"breast":[119],"cancers.":[120]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-01-10T00:00:00"}